Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Biomed Research International|June 19, 2020
Costs and Cost Drivers of Providing Option B+ Services to Mother-Baby Pairs for PMTCT of HIV in Health Centre IV Facilities in Jinja District, UgandaAggrey D Mukose, Senait Kebede, Christine Muhumuza, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness AnalysisGerasimos Konidaris, Eleanor Paul, Andreas Kuznik, et al.
Therapeutic Advances in Medical Oncology|June 24, 2022
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50Nick Freemantle, Yingxin Xu, Florence R Wilson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2020
Real-world persistence with dupilumab among adults with atopic dermatitisJonathan I Silverberg, Emma Guttman-Yassky, Abhijit Gadkari, et al.
Frontiers in Oncology|April 21, 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancerJosephine Louella Feliciano, Dylan McLoone, Yingxin Xu, et al.
Acta Dermato-Venereologica|May 18, 2019
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity IndexLieneke F M Ariëns, Abhijit Gadkari, Harmieke van Os-Medendorp, et al.
Clinical Pharmacology and Therapeutics|August 19, 2022
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2Mohamed A Kamal, Andreas Kuznik, Luyuan Qi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study GroupJalid Sehouli, Dirk Stengel, Philipp Harter, et al.
Future Oncology (London, England)|October 14, 2020
Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinomaSam Keeping, Yingxin Xu, Chieh-I Chen, et al.
Pageof 8